News

July 16, 2018July 16, 2018

Kineret Now Available in UK for Systemic-onset JIA and Still’s Disease

News

Kineret (anakinra), developed by Sobi, is now available as a treatment option in the United Kingdom for patients with systemic-onset juvenile idiopathic arthritis (SJIA) and adult-onset Still’s disease (AOSD). ... Read more

July 9, 2018July 9, 2018

Enrollment Complete for Phase 4 Trial Assessing H.P. Acthar Gel in Rheumatoid Arthritis

News

The phase 4 study evaluating H.P. Acthar Gel in patients with rheumatoid arthritis exceeded its enrollment goal, Mallinckrodt Pharmaceuticals announced. The ongoing study enrolled more than 230 adult patients ... Read more

June 29, 2018June 29, 2018

JIA Children with Treatment Can Attain Quality of Life Comparable to Healthy Peers, Study Says

News

Treating children with juvenile idiopathic arthritis (JIA) helps them to achieve a quality of life comparable to that of any healthy child, and that is a realistic clinical goal, a German ... Read more

June 25, 2018June 25, 2018

60% of JIA Patients Who Stop Taking Enbrel Experience Relapses, Study Finds

News

A significant number of patients with juvenile idiopathic arthritis (JIA) who stop taking Enbrel (etanercept) experience relapses. This happens more frequently in males and in patients with antinuclear antibodies and ... Read more

June 22, 2018June 22, 2018

New Study to Determine if Arthritis Patients May Be Able to Successfully Reduce Medication

News

A new study by Canadian researchers will explore the possibility of reducing medication for arthritis patients whose disease has already been under control for a certain period of time. ... Read more

June 18, 2018June 18, 2018

AbbVie, Eisai Launch Humira Pen Auto-injector in Japan for JA, Other Conditions

News

AbbVie GK in Japan and Eisai’s subsidiary EA Pharma recently launched an auto-injection delivery system for Humira (adalimumab) to help patients with chronic inflammatory conditions such as juvenile arthritis. The ... Read more

June 15, 2018June 15, 2018

Adults With JA Have Increased Risk of Developing Metabolic Syndrome, Survey Says

News

Data from a national survey showed that adults with juvenile arthritis were obese and at significantly higher risk of developing metabolic syndrome, according to a new study. The survey was ... Read more

June 11, 2018June 11, 2018

Adalimumab Shows Better Long-term Results than Infliximab for JIA-associated Uveitis, Study Finds

News

Adalimumab showed better long-term safety and efficacy results compared to infliximab in the treatment of juvenile idiopathic arthritis (JIA)-associated uveitis, or the inflammation of the eye’s middle layer, an Italian study ... Read more

June 8, 2018June 8, 2018

ANCON Raises Awareness for Juvenile Idiopathic Arthritis Via #WearPurpleforJIA Day

News

Today (June 8) is #WearPurpleforJIA day, and ANCON Medical is helping to raise awareness about juvenile idiopathic arthritis (JIA) and its effects on children with the condition. JIA is an ... Read more

June 4, 2018June 4, 2018

Depression in JIA Patients May Predict Long-term Pain and Disability, Study Finds

News

In adolescents with juvenile idiopathic arthritis (JIA), high levels of depression at the time of their diagnosis may predict future pain and disability, according to researchers in the U.K. ... Read more

Pin It on Pinterest